166 related articles for article (PubMed ID: 12072086)
1. CD30-positive cutaneous T-cell lymphoma with concurrent solid tumour.
Au WY; Yeung CK; Chan HH; Wong RW; Shek TW
Br J Dermatol; 2002 Jun; 146(6):1091-5. PubMed ID: 12072086
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
3. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
[TBL] [Abstract][Full Text] [Related]
5. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.
Chang SE; Park IJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Br J Dermatol; 2000 Apr; 142(4):766-70. PubMed ID: 10792229
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation.
Li G; Salhany KE; Rook AH; Lessin SR
J Cutan Pathol; 1997 Aug; 24(7):403-8. PubMed ID: 9274957
[TBL] [Abstract][Full Text] [Related]
7. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.
Mori M; Manuelli C; Pimpinelli N; Mavilia C; Maggi E; Santucci M; Bianchi B; Cappugi P; Giannotti B; Kadin ME
Blood; 1999 Nov; 94(9):3077-83. PubMed ID: 10556192
[TBL] [Abstract][Full Text] [Related]
8. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas.
Kaudewitz P; Burg G
Semin Diagn Pathol; 1991 May; 8(2):117-24. PubMed ID: 1651550
[No Abstract] [Full Text] [Related]
9. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen.
Gianotti R; Alessi E; Cavicchini S; Berti E
Am J Dermatopathol; 1991 Oct; 13(5):503-8. PubMed ID: 1659246
[TBL] [Abstract][Full Text] [Related]
10. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
14. ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course.
Wehkamp U; Oschlies I; Nagel I; Brasch J; Kneba M; Günther A; Klapper W; Weichenthal M
J Cutan Pathol; 2015 Nov; 42(11):870-7. PubMed ID: 26053561
[TBL] [Abstract][Full Text] [Related]
15. [A spontaneously resolving T-cell lymphoma].
Mutsaers ER; Willemze R; van Rossum MM
Ned Tijdschr Geneeskd; 2011; 155(45):A3930. PubMed ID: 22085572
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
Willemze R; Beljaards RC
J Am Acad Dermatol; 1993 Jun; 28(6):973-80. PubMed ID: 8388410
[TBL] [Abstract][Full Text] [Related]
17. TCR-γ expression in primary cutaneous T-cell lymphomas.
Rodríguez-Pinilla SM; Ortiz-Romero PL; Monsalvez V; Tomás IE; Almagro M; Sevilla A; Camacho G; Longo MI; Pulpillo Á; Diaz-Pérez JA; Montes-Moreno S; Castro Y; Echevarría B; Trébol I; Gonzalez C; Sánchez L; Otín AP; Requena L; Rodríguez-Peralto JL; Cerroni L; Piris MÁ
Am J Surg Pathol; 2013 Mar; 37(3):375-84. PubMed ID: 23348211
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of CD30-positive anaplastic large cell lymphoma and mycosis fungoides.
Kang SK; Chang SE; Choi JH; Sung KJ; Moon KC; Koh JK
Clin Exp Dermatol; 2002 May; 27(3):212-5. PubMed ID: 12072011
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
Wood GS
Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
